BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38232937)

  • 1. Prospective Randomized Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy of 25 Gy in 5 Fractions Compared With 35 Gy in 5 Fractions in the Reirradiation of Recurrent Glioblastoma.
    Chen ATC; Serante AR; Ayres AS; Tonaki JO; Moreno RA; Shih H; Gattás GS; Lopez RVM; Dos Santos de Jesus GR; de Carvalho IT; Marotta RC; Marta GN; Feher O; Neto HS; Ribeiro ISN; Vasconcelos KGMDC; Figueiredo EG; Weltman E
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1122-1132. PubMed ID: 38232937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED
    Kumar AMS; Miller J; Hoffer SA; Mansur DB; Coffey M; Lo SS; Sloan AE; Machtay M
    J Neurooncol; 2018 Sep; 139(2):449-454. PubMed ID: 29749569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status and recent advances in reirradiation of glioblastoma.
    Minniti G; Niyazi M; Alongi F; Navarria P; Belka C
    Radiat Oncol; 2021 Feb; 16(1):36. PubMed ID: 33602305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse.
    Tong E; Horsley P; Wheeler H; Wong M; Venkatesha V; Chan J; Kastelan M; Back M
    J Neurooncol; 2024 May; 168(1):69-76. PubMed ID: 38551747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
    Fokas E; Wacker U; Gross MW; Henzel M; Encheva E; Engenhart-Cabillic R
    Strahlenther Onkol; 2009 Apr; 185(4):235-40. PubMed ID: 19370426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial.
    Maranzano E; Anselmo P; Casale M; Trippa F; Carletti S; Principi M; Loreti F; Italiani M; Caserta C; Giorgi C
    Tumori; 2011; 97(1):56-61. PubMed ID: 21528665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated stereotactic reirradiation for recurrent glioblastoma.
    Yazici G; Cengiz M; Ozyigit G; Eren G; Yildiz F; Akyol F; Gurkaynak M; Zorlu F
    J Neurooncol; 2014 Oct; 120(1):117-23. PubMed ID: 25012955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising outcome of patients with recurrent glioblastoma after Gamma Knife-based hypofractionated radiotherapy.
    Hatiboglu MA; Akdur K; Sakarcan A; Seyithanoglu MH; Turk HM; Sinclair G; Oztanir MN
    Neurochirurgie; 2024 Mar; 70(2):101532. PubMed ID: 38215936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.
    Yilmaz MT; Kahvecioglu A; Yazici G; Mohammadipour S; Kertmen N; Cifci GC; Zorlu F
    J Neurooncol; 2024 Apr; 167(2):295-303. PubMed ID: 38383875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-irradiation with radiosurgery for recurrent glioblastoma multiforme.
    Torok JA; Wegner RE; Mintz AH; Heron DE; Burton SA
    Technol Cancer Res Treat; 2011 Jun; 10(3):253-8. PubMed ID: 21517131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience.
    Ciammella P; Podgornii A; Galeandro M; D'Abbiero N; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
    Radiat Oncol; 2013 Sep; 8():222. PubMed ID: 24066926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma.
    Napieralska A; Brąclik I; Radwan M; Mandera M; Blamek S
    Childs Nerv Syst; 2019 Feb; 35(2):267-275. PubMed ID: 30515559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme.
    Einstein DB; Wessels B; Bangert B; Fu P; Nelson AD; Cohen M; Sagar S; Lewin J; Sloan A; Zheng Y; Williams J; Colussi V; Vinkler R; Maciunas R
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):668-74. PubMed ID: 22445005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
    Lee J; Ahn SS; Chang JH; Suh CO
    Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
    Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
    Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
    J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.